According to Neuland Laboratories's latest financial reports the company has $17.06 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $5.53 M | 395.34% |
2022-03-31 | $1.11 M | -22.26% |
2021-03-31 | $1.43 M | -61.73% |
2020-03-31 | $3.75 M | -17.09% |
2019-03-31 | $4.52 M | 173.27% |
2018-03-31 | $1.65 M | -46.07% |
2017-03-31 | $3.07 M | 41.28% |
2016-03-31 | $2.17 M | 94.74% |
2015-03-31 | $1.11 M | -5.43% |
2014-03-31 | $1.18 M | 442.83% |
2013-03-31 | $0.21 M | -59.03% |
2012-03-31 | $0.53 M | -54.73% |
2011-03-31 | $1.17 M | -60.85% |
2010-03-31 | $2.99 M | 36.91% |
2009-03-31 | $2.18 M |